Current
Neuro-Oncology


Volume 22 Number 6
June 2020


Home > Publications > Current Neuro-Oncology > Volume 22, Year 2020 > Number 6, June


Contents


CENTRAL NERVOUS SYSTEM TUMORS




GLIOMAS


HIGH-GRADE GLIOMAS


LOW-GRADE GLIOMAS




DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS


GLIOBLASTOMA


GLIOSARCOMA


DIFFUSE MIDLINE GLIOMA




OTHER ASTROCYTIC TUMORS


SUBEPENDYMAL GIANT CELL ASTROCYTOMA




TUMORS OF THE PINEAL REGION




EMBRYONAL TUMORS


MEDULLOBLASTOMA


ATYPICAL THERATOID/RHABDOID TUMOR




MENINGIOMAS


MENINGIOMA




LYMPHOMAS




FAMILIAL TUMOR SYNDROMES




METASTATIC TUMORS





Central nervous system tumors

Phase 1 study

Nicolaides T, Nazemi KJ, Crawford J, Kilburn L, Minturn J, Gajjar A, Gauvain K, Leary S, Dhall G, Aboian M, Robinson G, Long-Boyle J, Wang H, Molinaro AM, Mueller S, Prados M.
Phase I study of vemurafenib in children with recurrent or progressive BRAFV600E mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002).
Oncotarget. 2020 May 26. 2020;11(21):1942-1952. Doi 10.18632/oncotarget.27600. _



Prospective study

O'Neil SH, Whitaker AM, Kayser K, Nelson MB, Finlay JL, Dhall G, Sands S.
Neuropsychological outcomes on Head Start III: a prospective, multi-institutional clinical trial for young children diagnosed with malignant brain tumors.
Neurooncol Pract. 2020 Feb 3. 2020;7(3):329-337. Doi 10.1093/nop/npz071. _



In vivo study

Zhao P, Le Z, Liu L, Chen Y.
Therapeutic Delivery to the Brain via the Lymphatic Vasculature.
Nano Lett. 2020 Jun 8. 2020;20(7):5415-5420. Doi 10.1021/acs.nanolett.0c01806. _



Gliomas

In vitro/in vivo study

Chang CY, Pan PH, Li JR, Ou YC, Wang JD, Liao SL, Chen WY, Wang WY, Chen CJ.
Aspirin Induced Glioma Apoptosis through Noxa Upregulation.
Int J Mol Sci. 2020 Jun 13. 2020;21(12):E4219. Doi 10.3390/ijms21124219. _



Phase 1 study

Mellinghoff IK, Ellingson BM, Touat M, Maher E, De La Fuente MI, Holdhoff M, Cote GM, Burris H, Janku F, Young RJ, Huang R, Jiang L, Choe S, Fan B, Yen K, Lu M, Bowden C, Steelman L, Pandya SS, Cloughesy TF, Wen PY.
Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Advanced Glioma.
J Clin Oncol. 2020 Jun 12. 2020:JCO1903327. Doi 10.1200/JCO.19.03327. _



Case-control study

Mousavi SM, Shayanfar M, Rigi S, Mohammad-Shirazi M, Sharifi G, Esmaillzadeh A.
Adherence to the Mediterranean dietary pattern in relation to glioma: A case-control study.
Clin Nutr. 2020 May 22. 2020;S0261-5614(20)30256-9. Doi 10.1016/j.clnu.2020.05.022. _



Retrospective study

Winter SF, Vaios EJ, Muzikansky A, Martinez-Lage M, Bussière MR, Shih HA, Loeffler J, Karschnia P, Loebel F, Vajkoczy P, Dietrich J.
Defining Treatment-Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment-Induced Necrosis.
Oncologist. 2020 Jun 2. 2020;10.1634/theoncologist.2020-0085. Doi 10.1634/theoncologist.2020-0085. _



In vitro/in vivo study

Zhao Z, Shen J, Zhang L, Wang L, Xu H, Han Y, Jia J, Lu Y, Yu R, Liu H.
Injectable postoperative enzyme-responsive hydrogels for reversing temozolomide resistance and reducing local recurrence after glioma operation.
Biomater Sci. 2020 Jun 23. 2020;10.1039/d0bm00338g. Doi 10.1039/d0bm00338g. _



High-grade gliomas


Prospective phase 1 study

Cohen AL, Anker CJ, Johnson B, Burt LM, Shrieve DC, Salzman K, Jensen R, Boucher K, Colman H.
Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial.
J Neurooncol. 2020 Jun 6. 2020;10.1007/s11060-020-03551-3. Doi 10.1007/s11060-020-03551-3. _



Low-grade gliomas


Prospective study

Kandels D, Pietsch T, Bison B, Warmuth-Metz M, Thomale UW, Kortmann RD, Timmermann B, Driever PH, Witt O, Schmidt R, Gnekow AK.
Loss of efficacy of subsequent non-surgical therapy after primary treatment failure in pediatric low-grade glioma patients - report from the German SIOP-LGG 2004 cohort.
Int J Cancer. 2020 Jun 24. 2020;10.1002/ijc.33170. Doi 10.1002/ijc.33170. _



Retrospective study

Nellan A, Wright E, Campbell K, Davies KD, Donson AM, Amani V, Judd A, Hemenway MS, Raybin J, Foreman NK, Rush S, Dorris K.
Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma.
J Neurooncol. 2020 Jun 6. 2020;10.1007/s11060-020-03549-x. Doi 10.1007/s11060-020-03549-x. _



Case report

Sumi K, Shijo K, Igarashi T, Yamamuro S, Sasano M, Oshima H, Ishige T, Honma T, Yagasaki H, Yoshino A.
Tectal Low-Grade Glioma with H3 K27M Mutation.
World Neurosurg. 2020 Jun 4. 2020;141:91-100. Doi 10.1016/j.wneu.2020.05.240. _



In vitro study
Nomogram construction

Wang C, Qiu J, Chen S, Li Y, Hu H, Cai Y, Hou L.
Prognostic model and nomogram construction based on autophagy signatures in lower grade glioma.
J Cell Physiol. 2020 Jun 9. 2020;10.1002/jcp.29837. Doi 10.1002/jcp.29837. _



Retrospective study

Wang J, Yan L, Ai P, He Y, Guan H, Wei Z, He L, Mu X, Liu Y, Peng X.
Observation versus radiotherapy with or without temozolomide in postoperative WHO grade II high-risk low-grade glioma: a retrospective cohort study.
Neurosurg Rev. 2020 Jun 11. 2020;10.1007/s10143-020-01326-y. Doi 10.1007/s10143-020-01326-y. _



Diffuse astrocytic and oligodendroglial tumors



Glioblastoma


Case report

Almahariq F, Raguž M, Dlaka D, Marčinković P, Kaštelančić A, Orešković D, Chudy D.
Glioblastoma Multiforme developed in site of Motor Cortex Stimulation.
Neurochirurgie. 2020 Jun 23. 2020:S0028-3770(20)30341-6. Doi 10.1016/j.neuchi.2020.05.004. _



Retrospective study

Bakas S, Shukla G, Akbari H, Erus G, Sotiras A, Rathore S, Sako C, Min Ha S, Rozycki M, Shinohara RT, Bilello M, Davatzikos C.
Overall survival prediction in glioblastoma patients using structural magnetic resonance imaging (MRI): advanced radiomic features may compensate for lack of advanced MRI modalities.
J Med Imaging (Bellingham). 2020 Jun 9. 2020;7(3):031505. Doi 10.1117/1.JMI.7.3.031505.. _



Comment

Bayik D, Watson DC, Lathia JD.
Release the ballast: Glioblastoma rises above radiation therapy by exporting miR-603 in extracellular vesicles to become treatment-resistant.
EBioMedicine. 2020 Jun 7. 2020;56:102788. Doi 10.1016/j.ebiom.2020.102788. _
Refers to: Ramakrishnan V, et al.,Radiation-induced extracellular vesicle (EV) release of miR-603 promotes IGF1-mediated stem cell state in glioblastomas. EBioMedicine. 2020 Apr 28. 2020;55:102736. Doi 10.1016/j.ebiom.2020.102736. _



In vitro study
Nomogram development

Cai HQ, Liu AS, Zhang MJ, Liu HJ, Meng XL, Qian HP, Wan JH.
Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of Glioblastomas.
Front Oncol. 2020 May 22. 2020;10:669. Doi 10.3389/fonc.2020.00669. _



Case report

Climans SA, Voruganti IS, Munoz DG, Mason WP.
Glioblastoma spinal cord metastasis with short-term clinical improvement after radiation.
Can J Neurol Sci. 2020 Jun 11. 2020;1-10. Doi 10.1017/cjn.2020.122. _



Prospective study

D'alessandris QG, Martini M, Cenci T, Di Bonaventura R, Lauretti L, Stumpo V, Olivi A, Larocca LM, Pallini R, Montano N.
Tailored therapy for recurrent glioblastoma. Report of a personalized molecular approach.
J Neurosurg Sci. 2020 Jun 17. 2020;10.23736/S0390-5616.20.04943-7. Doi 10.23736/S0390-5616.20.04943-7.. _



Retrospective study

De Barros A, Attal J, Roques M, Nicolau J, Sol JC, Charni S, Cohen-Jonathan-Moyal E, Roux FE.
Glioblastoma survival is better analyzed on preradiotherapy MRI than on postoperative MRI residual volumes: A retrospective observational study.
Clin Neurol Neurosurg. 2020 May 29. 2020;196:105972. Doi 10.1016/j.clineuro.2020.105972. _



Retrospective study

Delgado-Fernández J, Frade-Porto N, Blasco G, González-Tarno P, Gil-Simoes R, Li ZQ, Rivas PP, de Sola RG.
Does reintervention improve survival in recurrent glioblastoma? Facing a temporal bias in the literature.
Acta Neurochir (Wien). 2020 Jun 16. 2020;10.1007/s00701-020-04432-4. Doi 10.1007/s00701-020-04432-4. _



In vitro/in vivo study

García-Romero N, Palacín-Aliana I, Madurga R, Carrión-Navarro J, Esteban-Rubio S, Jiménez B, Collazo A, Pérez-Rodríguez F, Ortiz de Mendivil A, Fernández-Carballal C, García-Duque S, Diamantopoulos-Fernández J, Belda-Iniesta C, Prat-Acín R, Sánchez-Gómez P, Calvo E, Ayuso-Sacido A.
Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma.
BMC Med. 2020 Jun 22. 2020;18(1):142. Doi 10.1186/s12916-020-01610-0. _



Case report
Scientific rationale and considerations for future research

Gesundheit B, Ben-David E, Posen Y, Ellis R, Wollmann G, Schneider EM, Aigner K, Brauns L, Nesselhut T, Ackva I, Weisslein C, Thaller A.
Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series.
Front Oncol. 2020 May 14. 2020;10:702. doi: 10.3389/fonc.2020.00702. _



Prospective study

Gui C, Vannorsdall TD, Kleinberg LR, Assadi R, Moore JA, Hu C, Quiñones-Hinojosa A, Redmond KJ.
A Prospective Cohort Study of Neural Progenitor Cell-Sparing Radiation Therapy Plus Temozolomide for Newly Diagnosed Patients With Glioblastoma.
Neurosurgery. 2020 Jul 1. 2020;87(1):E31-E40. Do: 10.1093/neuros/nyaa107. _



Editorial

Haggiagi A, Lassman AB.
Newly diagnosed glioblastoma in the elderly: when is temozolomide alone enough?
Neuro Oncol. 2020 Jun 1. 2020;noaa136. Doi: 10.1093/neuonc/noaa136. _



Clinical trial

He X, Liu M, Zhang M, Sequeiros RB, Xu Y, Wang L, Liu C, Wang Q, Zhang K, Li C.
A novel three-dimensional template combined with MR-guided 125I brachytherapy for recurrent glioblastoma.
Radiat Oncol. 2020 Jun 8. 2020;15(1):146. Doi 10.1186/s13014-020-01586-4. _



Comment

Kotecha R, Mehta MP.
Extreme Hypofractionation for Newly Diagnosed Glioblastoma: Rationale, Dose, Techniques, and Outcomes.
Neuro Oncol. 2020 Jun 1. 2020;noaa133. Doi 10.1093/neuonc/noaa133. _
Refers to: Azoulay M, et al. A Phase I/II Trial of 5-Fraction Stereotactic Radiosurgery with 5-mm Margins with Concurrent Temozolomide in Newly Diagnosed Glioblastoma: Primary Outcomes. Neuro Oncol. 2020 Jan 31. 2020;noaa019. Doi 10.1093/neuonc/noaa019. _



Case report

Kumar A, Ballal S, Yadav MP, ArunRaj ST, Haresh KP, Gupta S, Damle NA, Garg A, Tripathi M, Bal C.
177Lu-/68Ga-PSMA Theranostics in Recurrent Glioblastoma Multiforme: Proof of Concept.
Clin Nucl Med. 2020 Jun 17. 2020;10.1097/RLU.0000000000003142. Doi 10.1097/RLU.0000000000003142.. _



Theoretical analysis

Li X, Yang F, Gao B, Yu X, Rubinsky B.
A Theoretical Analysis of the Effects of Tumor-Treating Electric Fields on Single Cells.
Bioelectromagnetics. 2020 Jun 8. 2020;10.1002/bem.22274. Doi 10.1002/bem.22274. _



Retrospective study

Marchionni A, Palumbo I, Montesi G, Bini V, Zucchetti C, Cenci N, Chiarini P, Saccia S, Aristei C, Lupattelli M.
Fractionated Stereotactic Sequential Boost in a Selected Cohort of Glioblastoma Patients: A Mono-institutional Analysis.
Anticancer Res. 2020 Jun;40(6):3387-3393. Doi 10.21873/anticanres.14322. _



Comment

Noll KR.
Commentary: Presurgical Identification of Patients With Glioblastoma at Risk for Cognitive Impairment at 3-Month Follow-up.
Neurosurgery. 2020 Jun 8. 2020;nyaa234. Doi 10.1093/neuros/nyaa234. _
Refers to: Rijnen SJM, et al.,Presurgical Identification of Patients With Glioblastoma at Risk for Cognitive Impairment at 3-Month Follow-up. Neurosurgery. 2020 May 29. 2020;nyaa190. Doi 10.1093/neuros/nyaa190. _



Phase 1B study

Rahman MA, Brekke J, Arnesen V, Hannisdal MH, Navarro AG, Waha A, Herfindal L, Rygh CB, Bratland E, Brandal P, Haasz J, Oltedal L, Miletic H, Lundervold A, Lie SA, Goplen D, Chekenya M.
Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study.
Immun Inflamm Dis. 2020 Jun 24. 2020;10.1002/iid3.315. Doi 10.1002/iid3.315. _



In vitro/in vivo study

Ramakrishnan V, Xu B, Akers J, Nguyen T, Ma J, Dhawan S, Ning J, Mao Y, Hua W, Kokkoli E, Furnari F, Carter BS, Chen CC.
Radiation-induced extracellular vesicle (EV) release of miR-603 promotes IGF1-mediated stem cell state in glioblastomas.
EBioMedicine. 2020 Apr 28. 2020;55:102736. Doi 10.1016/j.ebiom.2020.102736. _



Case report

Rodrigues LF, Camacho AHDS, Spohr TCLSE.
Secondary glioblastoma metastasis outside the central nervous system in a young HIV-infected patient.
Ther Adv Med Oncol. 2020 May 18. 2020;12:1758835920923432. Doi 10.1177/1758835920923432. _



In vitro/in vivo study

Schweiger MW, Li M, Giovanazzi A, Fleming RL, Tabet EI, Nakano I, Würdinger T, Chiocca EA, Tian T, Tannous BA.
Extracellular Vesicles Induce Mesenchymal Transition and Therapeutic Resistance in Glioblastomas through NF-κB/STAT3 Signaling.
Adv Biosyst. 2020 Jun 9. 2020;e1900312. Doi 10.1002/adbi.201900312. _



Retrospective study

Seyve A, Lozano-Sanchez F, Thomas A, Mathon B, Tran S, Mokhtari K, Giry M, Marie Y, Capelle L, Peyre M, Carpentier A, Feuvret L, Sanson M, Hoang-Xuan K, Honnorat J, Delattre JY, Ducray F, Idbaih A.
Initial surgical resection and long time to occurrence from initial diagnosis are independent prognostic factors in resected recurrent IDH wild-type glioblastoma.
Clin Neurol Neurosurg. 2020 Jun 8. 2020;196:106006. Doi 10.1016/j.clineuro.2020.106006. _



Image analysis

Steed TC, Treiber JM, Taha B, Engin HB, Carter H, Patel KS, Dale AM, Carter BS, Chen CC.
Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.
J Neurooncol. 2020 Jun 15. 2020;10.1007/s11060-020-03550-4. Doi 10.1007/s11060-020-03550-4. _



In vitro study

Tang Y, Qing C, Wang J, Zeng Z.
DNA Methylation-based Diagnostic and Prognostic Biomarkers for Glioblastoma.
Cell Transplant. 2020 Jun 8. 2020;29:963689720933241. Doi 10.1177/0963689720933241. _



Case report

Turcotte K, Touchette CJ, Iorio-Morin C, Fortin D.
Successful management of glioblastoma chemotherapy-associated dysgeusia with gabapentin.
Can J Neurol Sci. 2020 Jun 5. 2020:1-10. Doi 10.1017/cjn.2020.115. _



Retrospective study

Wach J, Hamed M, Schuss P, Güresir E, Herrlinger U, Vatter H, Schneider M.
Impact of initial midline shift in glioblastoma on survival.
Neurosurg Rev. 2020 Jun 4. 2020;10.1007/s10143-020-01328-w. Doi 10.1007/s10143-020-01328-w. _



Retrospective study

Wijethilake N, Islam M, Ren H.
Radiogenomics model for overall survival prediction of glioblastoma.
Med Biol Eng Comput. 2020 Jun 3. 2020;58(8):1767-1777. Doi: 10.1007/s11517-020-02179-9. _



Retrospective study

Zur I, Tzuk-Shina T, Guriel M, Eran A, Kaidar-Person O.
Survival impact of the time gap between surgery and chemo-radiotherapy in Glioblastoma patients.
Sci Rep. 2020 Jun 12. 2020;10(1):9595. Doi 10.1038/s41598-020-66608-3. _



Gliosarcoma


Case report

Jeng F, Reynolds A.
Retrobulbar chlorpromazine injection in a child with gliosarcoma invasion into the orbits.
BMJ Case Rep. 2020 Jun 9. 2020;13(6):e233394. Doi 10.1136/bcr-2019-233394. _



Diffuse midline glioma


In vitro study

Chen LH, Pan C, Diplas BH, Xu C, Hansen LJ, Wu Y, Chen X, Geng Y, Sun T, Sun Y, Zhang P, Wu Z, Zhang J, Li D, Zhang Y, Wu W, Wang Y, Li G, Yang J, Wang X, Xu C, Wang S, Waitkus MS, He Y, McLendon RE, Ashley DM, Yan H, Zhang L.
The integrated genomic and epigenomic landscape of brainstem glioma.
Nat Commun. 2020 Jun 17. 2020;11(1):3077. Doi 10.1038/s41467-020-16682-y. _



Retrospective study

Crotty EE, Leary SES, Geyer JR, Olson JM, Millard NE, Sato AA, Ermoian RP, Cole BL, Lockwood CM, Paulson VA, Browd SR, Ellenbogen RG, Hauptman JS, Lee A, Ojemann JG, Vitanza NA.
Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.
J Neurooncol. 2020 Jun 16. 2020;10.1007/s11060-020-03558-w. Doi 10.1007/s11060-020-03558-w. _



Retrospective study

Leach JL, Roebker J, Schafer A, Baugh J, Chaney B, Fuller C, Fouladi M, Lane A, Doughman R, Drissi R, DeWire-Schottmiller M, Ziegler DS, Minturn JE, Hansford JR, Wang SS, Monje-Deisseroth M, Fisher PG, Gottardo NG, Dholaria H, Packer R, Warren K, Leary SES, Goldman S, Bartels U, Hawkins C, Jones BV.
MR Imaging features of Diffuse Intrinsic Pontine Glioma (DIPG) and Relationship to Overall Survival: Report from the International DIPG Registry.
Neuro Oncol. 2020 Jun 6. 2020;noaa140. Doi 10.1093/neuonc/noaa140. _



Case report

Lu VM, Brown DA, Daniels DJ.
Rare Diffuse Intrinsic Pontine Glioma Metastasis Throughout the Brain and Spine.
World Neurosurg. 2020 May 28. 2020;140:301-302. Doi 10.1016/j.wneu.2020.05.205. _



Other astrocytic tumors



Subependymal giant cell astrocytoma


Case report

Barnes A, Wang MM, Feltes J, Ko J, Guzman MA.
Subependymal Giant-cell Astrocytoma Masquerading as Restrictive Eating Disorder and Depression in an Adolescent.
Innov Clin Neurosci. 2020 Jan 1. 2020;17(1-3):10-13. _



Tumors of the pineal region

Retrospective study

Liu W, Raynald, Tian Y, Gong J, Ma Z, Ma'ruf L, Li C.
Simultaneous single-trajectory endoscopic biopsy and third ventriculostomy in pediatric pineal region tumors.
Acta Neurol Belg. 2020 Jun 6. 2020;10.1007/s13760-020-01387-2. Doi 10.1007/s13760-020-01387-2. _



Retrospective study

Schulz M, Afshar-Bakshloo M, Koch A, Capper D, Driever PH, Tietze A, Grün A, Thomale UW.
Management of pineal region tumors in a pediatric case series.
Neurosurg Rev. 2020 Jun 6. 2020;10.1007/s10143-020-01323-1. Doi 10.1007/s10143-020-01323-1. _



Embryonal tumors



Medulloblastoma


In vitro study

Kesherwani V, Shukla M, Coulter DW, Sharp JG, Joshi SS, Chaturvedi NK.
Long non-coding RNA profiling of pediatric Medulloblastoma.
BMC Med Genomics. 2020 Jun 26. 2020;13(1):87. Doi 10.1186/s12920-020-00744-7. _



Case report

Li Y, Nonaka M, Kanemura Y, Kodama Y, Mano M, Asai A.
A case of medulloblastoma in a patient with fetal ventricular enlargement.
Childs Nerv Syst. 2020 Jun 18. 2020;10.1007/s00381-020-04725-0. Doi 10.1007/s00381-020-04725-0. _



Prospective study

Madan R, Kumar N, Gupta A, Gupta K, Salunke P, Khosla D, Yadav BS, Kapoor R.
Effect of prophylactic granulocyte-colony stimulating factor (G-CSF) on acute hematological toxicity in medulloblastoma patients during craniospinal irradiation (CSI).
Clin Neurol Neurosurg. 2020 May 28. 2020;196:105975. Doi 10.1016/j.clineuro.2020.105975. _



Retrospective study

Massimino M, Sunyach MP, Barretta F, Gandola L, Garegnani A, Pecori E, Spreafico F, Bonneville-Levard A, Meyronet D, Mottolese C, Boschetti L, Biassoni V, Schiavello E, Giussani C, Carrabba G, Diletto B, Pallotti F, Stefini R, Ferrari A, Terenziani M, Casanova M, Luksch R, Meazza C, Podda M, Chiaravalli S, Puma N, Bergamaschi L, Morosi C, Calareso G, Giangaspero F, Antonelli M, Buttarelli FR, Frappaz D.
Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients.
J Neurooncol. 2020 Jun 21. 2020;10.1007/s11060-020-03564-y. Doi 10.1007/s11060-020-03564-y. _



Retrospective study

Frič R, Due-Tønnessen BJ, Lundar T, Egge A, Kronen Krossnes B, Due-Tønnessen P, Stensvold E, Brandal P.
Long-term outcome of posterior fossa medulloblastoma in patients surviving more than 20 years following primary treatment in childhood.
Sci Rep. 2020 Jun 10. 2020;10(1):9371. Doi 10.1038/s41598-020-66328-8. _



Retrospective study

Reddy N, Ellison DW, Soares BP, Carson KA, Huisman TAGM, Patay Z.
Pediatric Posterior Fossa Medulloblastoma: The Role of Diffusion Imaging in Identifying Molecular Groups.
J Neuroimaging. 2020 Jun 12. 2020;10.1111/jon.12704. Doi 10.1111/jon.12704. _



Retrospective study

Sedano P, Segundo CG, De Ingunza L, Cuesta-Álvaro P, Pérez-Somarriba M, Diaz-Gutiérrez F, Colino CG, Lassaletta A.
Real-world data for pediatric medulloblastoma: can we improve outcomes?
Eur J Pediatr. 2020 Jun 21. 2020;10.1007/s00431-020-03722-4. Doi 10.1007/s00431-020-03722-4. _



Retrospective study

Sharma R, Katiyar V, Gurjar H, Sharma M, Goda R, Vora Z.
Is medulloblastoma associated with systemic immunomodulation? - A comparative analysis of preoperative inflammatory markers.
Surg Neurol Int. 2020 May 2. 2020;11:86. Doi 10.25259/SNI_336_2019. _



Retrospective study

Wu T, Qu PR, Zhang S, Li SW, Zhang J, Wang B, Liu P, Li CD, Zhao F.
The clinical treatment and outcome of cerebellopontine angle medulloblastoma: a retrospective study of 15 cases.
Sci Rep. 2020 Jun 17. 2020;10(1):9769. Doi 10.1038/s41598-020-66585-7. _



Atypical theratoid/rhabdoid tumor


Case report

Krill MK, Fogarty AE, Jacob S.
A 71-year-old man with a rare rhabdoid brain tumour: using a multidisciplinary medical and rehabilitative model of care.
BMJ Case Rep. 2020 Jun 11. 2020;13(6):e231924. Doi 10.1136/bcr-2019-231924. _



Meningiomas



Meningioma


Retrospective study

Khayat Kashani HR, Azhari S, Nayebaghayee H, Salimi S, Mohammadi HR.
Prediction value of preoperative findings on meningioma grading using artificial neural network.
Clin Neurol Neurosurg. 2020 May 20. 2020;196:105947. Doi 10.1016/j.clineuro.2020.105947. _



Lymphomas

Case report

Ferrer P, Barbero P, Monedero G, Presti AL, Bejarano B, Penanes JR.
Primary central nervous system lymphoma and 5-aminolevulinic acid.
Surg Neurol Int. 2020 May 23. 2020;11:122. Doi 10.25259/SNI_185_2020. _



Retrospective study

Roetzer T, Furtner J, Gesperger J, Seebrecht L, Bandke D, Brada M, Brandner-Kokalj T, Grams A, Haybaeck J, Kitzwoegerer M, Leber SL, Marhold F, Moser P, Sherif C, Trenkler J, Unterluggauer J, Weis S, Wuertz F, Hainfellner JA, Langs G, Nenning KH, Woehrer A.
Sex-Specific Differences in Primary CNS Lymphoma.
Cancers (Basel). 2020 Jun 16. 2020;12(6):E1593. Doi 10.3390/cancers12061593. _



Familial tumor syndromes

Retrospective study

Santoro C, Picariello S, Palladino F, Spennato P, Melis D, Roth J, Cirillo M, Quaglietta L, D'Amico A, Gaudino G, Meucci MC, Ferrara U, Constantini S, Perrotta S, Cinalli G.
Retrospective Multicentric Study on Non-Optic CNS Tumors in Children and Adolescents with Neurofibromatosis Type 1.
Cancers (Basel). 2020 May 31. 2020;12(6):E1426. Doi 10.3390/cancers12061426. _



Metastatic tumors

Prospective study

Jung J, Tailor J, Dalton E, Glancz LJ, Roach J, Zakaria R, Lammy S, Chari A, Budohoski KP, Livermore LJ, Yu K, Jenkinson MD, Brennan PM, Brazil L, Bunce C, Bourmpaki E, Ashkan K, Vergani F.
Management evaluation of metastasis in the brain (MEMBRAIN)-a United Kingdom and Ireland prospective, multicenter observational study.
Neurooncol Pract. 2019 Dec 6. 2020;7(3):344-355. Doi: 10.1093/nop/npz063. _



bottom